Investee Company News

April 27, 2017 Novan Presents Safety Data for SB204 Program April 27, 2017 Novan Presents Preclinical Data from Inflammatory Skin Diseases Program April 21, 2017 Melinta Therapeutics Updates Pyrrolocytosine and Enhanced Macrolide Programs at ECCMID Showcasing Company’s Structure-Based Drug Design April 21, 2017 Melinta Therapeutics Presentations at ECCMID Show Potential of Baxdela in Obese and other Challenging Patient Types April 19, 2017 Melinta Therapeutics Highlighting Activity of Baxdela as well as Progress on Macrolide and Pyrrolocytosine Candidates at ECCMID 2017 April 12, 2017 Novan Reports Positive Topline Results with SB208 in Phase 2 Trial April 4, 2017 Novan Welcomes Key Opinion Leaders to New Advisory Council April 4, 2017 Poseida Therapeutics Presents Preclinical Data Demonstrating Multiple Therapeutic Advantages from BCMA-Specific CAR-T Program at AACR April 4, 2017 3D4Medical announces the appointment of top medical professionals to its Medical Advisory Board April 3, 2017 Xenex Announces New 2-Minute Run-Time for OR Disinfection with LightStrike Germ-Zapping Robots™ at AORN Surgical Conference & Expo March 30, 2017 Henry Ford and HonorHealth are First Health Systems to Deploy Xenex LightStrike Germ-Zapping Robots Across All Hospitals March 22, 2017 Novan Reshapes Executive Management Team March 20, 2017 Novan Reports Fourth Quarter and Full Year 2016 Financial Results March 6, 2017 Viamet Presents Positive Results from Phase 2b Trial of VT-1161 in Onychomycosis at AAD March 6, 2017 Novan Provides Update on SB204 Development Program March 2, 2017 Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 Countries March 2, 2017 Novan’s Phase 2 Results with SB206 to be Presented at 2017 AAD Annual Meeting March 1, 2017 Novan Announces Presentation of Anti-Viral Data at International Papillomavirus Conference March 1, 2017 Viamet Announces RENOVATE Phase 2b Onychomycosis Results to be Presented at the AAD 2017 Annual Meeting February 28, 2017 Melinta Announces FDA Acceptance of Investigational New Drug Application for Topical Radezolid February 27, 2017 Melinta Therapeutics Provides Baxdela NDA Update February 24, 2017 Xenex Secures $38 Million in Funding Led by Essex Woodlands & Piper Jaffray Merchant Banking February 22, 2017 3D4Medical Announces the Appointment of Top Academics to Its Academic Review Board February 13, 2017 Xenex LightStrike Germ-Zapping Robots Battling Superbugs in UK; Infection Prevention & Control Conference Will Feature Pulsed Xenon Light Disinfection Technology January 27, 2017 Novan Reports Topline Results from SB204 Phase 3 Pivotal Trials January 26, 2017 Anne Whitaker Named CEO of KNOW Bio Respiratory Company January 23, 2017 Kymab appoints Dr Arndt Schottelius as Executive Vice President Research & Development January 17, 2017 Novan Licenses SB204 to Sato for Acne in Japan January 9, 2017 Kymab Expands Infectious Disease Programmes January 6, 2017 Viamet Reports Positive Results from REVIVE Phase 2b Trial of Oral VT-1161 in Recurrent Vulvovaginal Candidiasis